Emergency and ICU pharmacists would be most likely to see pneumonic plague. An expert reviews first-line agents, alternatives, and postexposure prophylaxis.
|Videos|November 17, 2017
The Role of the Pharmacist in Heart Failure Management
In this clip taken at the American Heart Association 2017 Scientific Sessions, Amar Bhakta, MD, from Rush University Medical Center, explains the crucial role that pharmacists play in the management of heart failure. Pharmacists are in a unique position to provide patient education, ensure medication adherence, and assess the patient's symptoms.
Advertisement
In this clip taken at the American Heart Association 2017 Scientific Sessions, Amar Bhakta, MD, from Rush University Medical Center, explains the crucial role that pharmacists play in the management of heart failure. Pharmacists are in a unique position to provide patient education, ensure medication adherence, and assess the patient's symptoms.
Advertisement
Related to this article
A former residency program director unpacks why this debate keeps resurfacing, and why some reasons people give for skipping residency may not hold up the way they think they do.
Eric Lawitz, MD, explains how pharmacists can raise liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
3
Pneumonic Plague: What Pharmacists Need to Know About Treatment
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5